© 1993 British Society for Rheumatology
research-article |
A TWO-YEAR, PLACEBO-CONTROLLED TRIAL OF NON-STEROIDAL ANTI-INFLAMMATORY THERAPY IN OSTEOARTHRITIS OF THE KNEE JOINT
*Department of Rheumatology Horsham, Sussex
Department of Radiology Bristol Royal Infirmary Horsham, Sussex
Department of Ciba-Geigy Pharmaceuticals Division Horsham, Sussex
Correspondence to:
Correspondence to: P. Dieppe, Rheumatology Unit, Bristol Royal Infirmary Bristol BS2 8HW
Eighty-nine patients with established OA of the knee joint, already on regular NSAIDs for joint pain, were randomly allocated to receive lOOmg/day of slow release diclofenac (45 patients) or matching placebo (44), in place of their NS AID, for 2 years.
Thirty-eight patients withdrew or dropped out of the study. The major causes for withdrawal were lack of efficacy (three active, 12 placebo, P<0.01) or side effects (six active, five placebo), and most withdrawals occurred within the first 6 months. Long term follow up of these patients was not possible.
Fifty-one patients completed the study (31 active, 20 placebo), 35 of whom reported that they were the same or better at the end of the 2-year period than at the beginning. Most of the recorded clinical parameters showed little or no change over 2 years in these 51 subjects, and in 70% there was no detectable change in the radiographs.
We conclude that long term placebo-controlled trials are both feasible and ethical in knee OA, but that conventional clinical and radiographic techniques detect very little change in joint structure or function over a 2-year time period. This may reflect the insensitivity of the methods used to assess progression rather than absence of change. The fact that 20 of 44 patients changed from an NSAID to placebo completed the 2-year study without any symptomatic penalty indicates that not all patients entered needed or responded to NSAIDs.
KEY WORDS: Osteoarthritis, Knee joint, NSAID, Controlled trial, Radiology
: Present address: Queen Alexandra Hospital, Cosham, Hants.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Latimer, J. Lord, R. L Grant, R. O'Mahony, J. Dickson, P. G Conaghan, and on behalf of the National Institute for Health and Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis BMJ, July 14, 2009; 339(jul14_1): b2538 - b2538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Brandt, S. A. Mazzuca, and K. A. Buckwalter Acetaminophen, like conventional NSAIDs, may reduce synovitis in osteoarthritic knees Rheumatology, November 1, 2006; 45(11): 1389 - 1394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Rintelen, K. Neumann, and B. F. Leeb A Meta-analysis of Controlled Clinical Studies With Diacerein in the Treatment of Osteoarthritis. Arch Intern Med, September 25, 2006; 166(17): 1899 - 1906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Weigl, F Angst, G Stucki, S Lehmann, and A Aeschlimann Inpatient rehabilitation for hip or knee osteoarthritis: 2 year follow up study Ann Rheum Dis, April 1, 2004; 63(4): 360 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A E Wluka, R Wolfe, S Stuckey, and F M Cicuttini How does tibial cartilage volume relate to symptoms in subjects with knee osteoarthritis? Ann Rheum Dis, March 1, 2004; 63(3): 264 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Case, A. Baliunas, and J. A. Block What Now About Acetaminophen?--Reply Arch Intern Med, August 11, 2003; 163(15): 1863 - 1863. [Full Text] [PDF]
|
|
|
|
|
|
D. L. Scott, H. Berry, H. Capell, J. Coppock, T. Daymond, D. V. Doyle, L. Fernandes, B. Hazleman, J. Hunter, E. C. Huskisson, et al. The long-term effects of non-steroidal anti-inflammatory drugs in osteoarthritis of the knee: a randomized placebo-controlled trial Rheumatology, October 1, 2000; 39(10): 1095 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ravaud, B. Giraudeau, G.-R. Auleley, J.-L. Drape, B. Rousselin, L. Paolozzi, C. Chastang, and M. Dougados Variability in knee radiographing: implication for definition of radiological progression in medial knee osteoarthritis Ann Rheum Dis, October 1, 1998; 57(10): 624 - 629. [Abstract] [Full Text]
|
|
|
|
|
|
G.-R. Auleley, B. Rousselin, X. Ayral, R. Edouard-Noel, M. Dougados, and P. Ravaud Osteoarthritis of the hip: agreement between joint space width measurements on standing and supine conventional radiographs Ann Rheum Dis, September 1, 1998; 57(9): 519 - 523. [Abstract] [Full Text]
|
|
|
|
 |
|
 What can be done about osteoarthritis? DTB, May 1, 1996; 34(5): 33 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Griffin, K. D. Brandt, M. H. Liang, T. Pincus, and W. A. Ray Practical Management of Osteoarthritis: Integration of Pharmacologic and Nonpharmacologic Measures Arch Fam Med, December 1, 1995; 4(12): 1049 - 1055. [Abstract] [PDF]
|
|
|
|
|
|
Rational use of NSAIDs for musculoskeletal disorders DTB, December 1, 1994; 32(12): 91 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Stucki, M. Johannesson, and M. H. Liang Is Misoprostol Cost-effective in the Prevention of Nonsteroidal Anti-inflammatory Drug--Induced Gastropathy in Patients With Chronic Arthritis? A Review of Conflicting Economic Evaluations Arch Intern Med, September 26, 1994; 154(18): 2020 - 2025. [Abstract] [PDF]
|
|